Ładuje się......
Weight Change During Chemotherapy as a Potential Prognostic Factor for Stage Iii Epithelial Ovarian Carcinoma: A Gynecologic Oncology Group Study
OBJECTIVE: Platinum/paclitaxel-based chemotherapy is a current treatment for advanced epithelial ovarian cancer. We sought to explore the association between weight change during treatment and survival, as well as the association between pre-chemotherapy body mass index (BMI) and survival. METHODS:...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2007
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2517223/ https://ncbi.nlm.nih.gov/pubmed/17675142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2007.06.010 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|